The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma
Authors:
Open Access
- 15 July 2022
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-17
Abstract
Background: As a DNA surveillance mechanism, cell cycle checkpoint has recently been discovered to be closely associated with lung adenocarcinoma (LUAD) prognosis. It is also an essential link in the process of DNA damage repair (DDR) that confers resistance to radiotherapy. Whether genes that have both functions play a more crucial role in LUAD prognosis remains unclear. Methods: In this study, DDR-related genes with cell cycle checkpoint function (DCGs) were selected to investigate their effects on the prognosis of LUAD. The TCGA-LUAD cohort and two GEO external validation cohorts (GSE31210 and GSE42171) were performed to construct a prognosis model based on the least absolute shrinkage and selection operator (LASSO) regression. Patients were divided into high-risk and low-risk groups based on the model. Subsequently, the multivariate COX regression was used to construct a prognostic nomogram. The ssGSEA, CIBERSORT algorithm, TIMER tool, CMap database, and IC50 of chemotherapeutic agents were used to analyze immune activity and responsiveness to chemoradiotherapy. Results: 4 DCGs were selected as prognostic signatures, and patients in the high-risk group had a lower overall survival (OS). The lower infiltration levels of immune cells and the higher expression levels of immune checkpoints appeared in the high-risk group. The damage repair pathways were upregulated, and chemotherapeutic agent sensitivity was poor in the high-risk group. Conclusions: The 4-DCGs signature prognosis model we constructed could predict the survival rate, immune activity, and chemoradiotherapy responsiveness of LUAD patients.Keywords
Funding Information
- the Scientific Research Project of Wenzhou Medical University for Talent (QTJ20010)
- National Natural Science Foundation of China (11635013)
This publication has 59 references indexed in Scilit:
- Macrophage Regulation of Tumor Responses to Anticancer TherapiesCancer Cell, 2013
- NBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaksOncogene, 2012
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapyNature Reviews Drug Discovery, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- DNA Damage Response as an Anti-Cancer Barrier: Damage Threshold and the Concept of 'Conditional Haploinsufficiency'Cell Cycle, 2007
- Polo-Like Kinases: A Team in Control of the DivisionCell Cycle, 2006
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative SurvivalCancer Research, 2004
- Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndromeClinical and Experimental Immunology, 2003
- Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed CellsMolecular and Cellular Biology, 2003
- The family of polo-like kinases1996